Future of the PBS Summit 2014
Confirming	
  the	
  financial	
  stability	
  of	
  the	
  PBS	
  	
  
and	
  	
  
Ensuring	
...
Stability – Certainty – Access
1.	
  “All	
  over,	
  bar	
  the	
  Budget”:	
  the	
  PBS	
  is	
  proven	
  
to	
  be	
 ...
PBS Expenditure
3
	
  $10,040	
  	
  
	
  $10,188	
  	
  
	
  $9,832	
  	
  
2010-­‐11	
   2011-­‐12	
   2012-­‐13	
  
PBS...
PBS expenditure in decline
4
Source:	
  Federal	
  Budget,	
  various	
  years;	
  Medicines	
  Partnership	
  of	
  Austr...
Pillars of the National Medicines Policy
at risk
5
Challenge has moved from sustainability
to access
6
72%	
  
61%	
  
55%	
  
57%	
  
24%	
  
32%	
  
36%	
  
33%	
  
4%	
  ...
7
International access to medicines
Source:	
  WyaS	
  Health,	
  Internaonal	
  Report	
  on	
  Access	
  to	
  Medicines...
International access to cancer
medicines
8
Source:	
  Cheema,	
  P.	
  2010	
  “Internaonal	
  
variability	
  in	
  the	
...
9
Additional medicines listed for
reimbursement in Australia that are
not reimbursed in NZ
0
5
10
15
20
2000 2001 2002 200...
Source:	
  PBS	
  (Australia),	
  PHARMAC	
  (NZ
Delays in NZ medicines
Molecule	
   Indications	
   Available in Aus
Sinc...
New Zealand: Our future?
11
•  Roune	
  delays	
  of	
  up	
  to	
  6	
  years	
  for	
  new	
  medicines	
  
•  Supply	
 ...
Conclusion
•  Two	
  possible	
  futures	
  for	
  the	
  PBS	
  face	
  us	
  today	
  
•  PBS	
  is	
  sustainable	
  du...
Upcoming SlideShare
Loading in …5
×

Dr Brendan Shaw - Medicines Australia - Examining the financial stability of the PBS and ensuring reform savings deliver new medicines in Australia as intended

784 views

Published on

Dr Brendan Shaw delivered the presentation at 2014 Future of the PBS Summit.

The 11th annual Future of the PBS Summit marks a wonderful opportunity to review future frameworks and preferred outcomes for pharmacy regulators, pharmaceutical companies and wholesalers, practitioners, educators and consumers.

For more information about the event, please visit: http://www.informa.com.au/futurepbs14

Published in: Business, Technology
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
784
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
14
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Dr Brendan Shaw - Medicines Australia - Examining the financial stability of the PBS and ensuring reform savings deliver new medicines in Australia as intended

  1. 1. Future of the PBS Summit 2014 Confirming  the  financial  stability  of  the  PBS     and     Ensuring  reforms  deliver  new  medicines 6 May 2014 Brendan Shaw, Medicines Australia CEO 1
  2. 2. Stability – Certainty – Access 1.  “All  over,  bar  the  Budget”:  the  PBS  is  proven   to  be  on  a  sustainable  path     2.  The  debate  should  be  about  access  to  new   medicines  for  all  Australians     2
  3. 3. PBS Expenditure 3  $10,040      $10,188      $9,832     2010-­‐11   2011-­‐12   2012-­‐13   PBS  Expenditure  2010/11-­‐2012/13  ($M)   Final  Budget  Outcome   PBS  as  a  share  of  total  Commonwealth  health  funding   Source:  Final  Budget  Outcome,  2013,  p.  97,   hSp://budget.gov.au/2012-­‐13/content/To/download/ 2012-­‐13_FBO_Consolidated.pdf,  accessed  5/5/2014   Source:  PharmaDispatch,  hSp://www.pharmadispatch.com/?pgnc=1.    
  4. 4. PBS expenditure in decline 4 Source:  Federal  Budget,  various  years;  Medicines  Partnership  of  Australia,   PBS  Scorecard,  February  2014,   hSp://medicinespartnership.com.au/category/pbs-­‐scorecards/,  accessed   5/5/2014  
  5. 5. Pillars of the National Medicines Policy at risk 5
  6. 6. Challenge has moved from sustainability to access 6 72%   61%   55%   57%   24%   32%   36%   33%   4%   7%   9%   10%   0%   10%   20%   30%   40%   50%   60%   70%   80%   2010   2011   2012   2013   Annual  recommendaon  rate,  rejecon  rate  and  deferral  rate  for   submissions  for  medicines  that  were  considered  by  the  PBAC  (2010  –   2013)   Recommenda@on  rate   (medicines)*   Rejec@on  rate  (medicines)*   Deferral  rate  (medicines)*   Source:  Michael  Wonder,  2014,  Unpublished  PBAC  data,  Wonder  Drug   Consulng  
  7. 7. 7 International access to medicines Source:  WyaS  Health,  Internaonal  Report  on  Access  to  Medicines,  2011-­‐12,   hSp://www.wyaShealth.com/wp-­‐content/uploads/IRAM/iram-­‐2011-­‐2012-­‐English.pdf,  p.  17,  access  5/5/2014.  
  8. 8. International access to cancer medicines 8 Source:  Cheema,  P.  2010  “Internaonal   variability  in  the  reimbursement  of  cancer  drugs   by  publically  funded  drug  programs”,  Medical   Oncology,  v.  19,  n.  3,   hSp://www.current-­‐oncology.com/index.php/ oncology/arcle/view/946/924    (accessed   4/10/2013  )  
  9. 9. 9 Additional medicines listed for reimbursement in Australia that are not reimbursed in NZ 0 5 10 15 20 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 NumberofMedicineslistedinAustralia Reimbursed in Aus and NZ Medicines that are reimbursed in Aus but not NZ Source:  PBS  (Australia),  PHARMAC  (NZ)  
  10. 10. Source:  PBS  (Australia),  PHARMAC  (NZ Delays in NZ medicines Molecule   Indications   Available in Aus Since:   Time b/w PBS Listing and PTAC Rec   Recommendation by PTAC   Time gap from Australian Recommendation   Rosuvastatin   Cholesterol   1/12/2006   8 months   1/08/2007   6 years 5 months   Buprenorphine hydrochloride   Severe pain   1/08/2001   7 years 8 months   1/05/2009   4 years 8 months   Nilotinib   Chronic myeloid leukaemia   1/08/2008   2 years 6 months   1/02/2011   2 years 11 months   Sorafenib   Advanced hepatocellular carcinoma   1/02/2009   2 years 9 months   1/11/2011   2 years 2 months  
  11. 11. New Zealand: Our future? 11 •  Roune  delays  of  up  to  6  years  for  new  medicines   •  Supply  chain  risks  leading  to  shortages   •  No  paent  or  doctor  choice   •  No  tailored  care  to  the  paent’s  condion   •  No  transparency  on  whether  and  when  a  medicine  may   appear  
  12. 12. Conclusion •  Two  possible  futures  for  the  PBS  face  us  today   •  PBS  is  sustainable  due  to  industry  efforts   •  The  pillar  of  access  is  failing  but  fixable   •  Australians  expect  a  first  class  medicines   system  in  a  first  world  country   12

×